A History of the Harm Reduction Movement Northern California - Kaiser Permanente Conference Presenter: Don McVinney, MSSW, M.Phil., ACSW, C-CATODSW, CASAC.

Slides:



Advertisements
Similar presentations
NATIONAL TOBACCO CONTROL 1. PREVENT TOBACCO USE AMONG YOUTH 2. REDUCE NUMBERS OF SMOKERS REDUCE TOBACCO CONSUMPTION 3. LIMIT ENVIRONMENTAL TOBACCO SMOKE.
Advertisements

TRI science addiction Lost Opportunity? SBI for Substance Abuse In ERs and Trauma Centers Academy Health Mady Chalk, Ph.D. Treatment Research Institute.
Introduction to Drug Misuse Les Goldman. Objectives Gain basic knowledge of Common current patterns of drug misuse Local referral pathways Available treatments.
TUTORIAL MODULE 3 ASBIRT Alabama Screening, Brief Intervention, Referral, and Treatment Program.
Harm Reduction for Young People: Why A Youth Network? Diane Riley, PhD Canadian Foundation for Drug Policy, Youth Network for Harm Reduction & University.
13 Principles of Effective Addictions Treatment
Harm Reduction Principles in Practice Part 1 of 3 What does H.R. actually mean? We will look at H.R. philosophy + how to incorporate it into informal and.
Integrated Dual Diagnosis Treatment
Models of Harm Reduction
Prevention strategies
Workforce development in the new Annette Dale- Perera Strategic Director of Addiction and Offender Care.
Dimensional Assessment for Co-Occurring Disorders 8 th Annual Prevention and Recovery Conference Todd Crawford, LPC, LADC Director, Residential Services.
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
TREATMENT CENTRE.  Principles of treatment  treatment goals - abstinence and harm reduction  Types of treatment  medical treatment  psychological.
November 16, 2012Harm Reduction Conference1 Cannabis as a facilitator of mindfulness: Implications for the treatment of addiction. Amanda Reiman, PhD MSW.
Canada’s Drug Strategy. 2 Purpose Provide an overview of Canada’s renewed National Drug Strategy  Historical context  Impetus for change  Renewed National.
Peterborough Drug Strategy
Harm Reduction Implementing Harm Reduction Strategies in Your Health Center.
Meeting the health needs of older drug users Dr Muriel Simmonte NHS Lothian Primary Care Facilitator Team/East Lothian Locality Drug Clinic.
New Pathways, New Connections: Tobacco and Behavioral Health Frances M. Harding, Director SAMHSA’s Center for Substance Abuse Prevention National Conference.
Back to the Future The changing face of harm reduction
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
Harm Reduction Presented by Mike Nielsen. Introduction Brief History Brief History Definition Definition Relationship to Therapy Relationship to Therapy.
Harm Reduction.
Overview of Harm Reduction and Sterile Syringe Access Anna Benyo Syringe Access Policy Coordinator Harm Reduction Coalition New Jersey Syringe Access Informational.
Perspectives on the Age Wave: Key Issues, Solutions, and Opportunities Robyn Golden, LCSW Director of Older Adult Programs Rush University Medical Center.
Treatment 101 Substance Abuse Basics West Coast Consulting Wanda King
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
1 First Clinic Visit for Patients with HIV Infection HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Responding to Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Janet M Urban Lung-2015 Baltimore, USA July , 2015.
The National Prevention Strategy and Behavioral Health Care: Prevention Is Now RADM Peter J. Delany, Ph.D., LCSW-C Substance Abuse and Mental Health Services.
A multi-disciplinary theory of drug-related harm reduction
Drunk Driving: A Strategy for Reducing Recidivism 12 th Annual Michigan Traffic Safety Summit Tuesday March 13, 2006 Bradley Finegood, MA, LLPC.
OPIOID SUBSTITUTION THERAPY
UNITED NATIONS Population Unit ECONOMIC COMMISSION FOR EUROPE Policy Brief on Health Promotion and Prevention of Disease.
Pathways to risk: What can we do? Ian Webster. “Ways of Seeing” Moral - legal issue Health - public health problem Psychosocial problems - education A.
NORTH SOMERSET SUBSTANCE MISUSE SERVICE Care forum update (September 2014) (The content of this presentation is subject to change).
A: New definitions of the 4 pillars used before Prevention New name: Reasoning: Substance abuse must be identified at an early stage and accordant measures.
Alcohol policy in Catalonia Joan Colom Antoni Gual Lidia Segura March 2007, Pécs, Baranya (H)
Reaching out to drug users and communities “ ” WDP Preventing HIV Yasmin Batliwala.
The British vs. American Models in history Drug addiction is illness Drug addiction is illness Medical model: based on controlled dispensation of drugs.
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
Australia’s Drug Policy Greg Denham Nossal Institute for Global Health.
HARM REDUCTION Bogotá November 2008 The Czech Republic in the heart of Europe.
Services for Veterans and Returning Soldiers A Brief Overview of Service Needs, Service Gaps, and Collaborative Efforts for in New York State.
Cathy Worthem, MSW Joyce Washburn, MPA BFSS, May 2011 Phoenix, AZ.
1 Kennedy Roberts Senior Medical Officer and Clinical Lead North Cluster Glasgow Addiction Services Community Addiction Teams What are the challenges for.
Lydia H. Guterman Consultant, Open Society Institute September 25, 2008 Sofia, Bulgaria Many thanks to the Harm Reduction Coalition for partial content.
Delivery Systems for Substance Abuse Treatment: Integration with Primary Care and Mental Health and Social Services (Also referred to as) Delivery Systems.
Chapter 15: Substance-Related Disorders and Addictive Behaviors Copyright © 2012, 2007 Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved.
© Copyright 2011, Pearson Education, Inc. All rights reserved. Chapter 2 Drug-Taking Behavior: The Personal and Social Concerns.
EU model – evidence based Out of 100% of people who tried drugs, only 10% get to chronicle stage Out of 100% of people who tried drugs, only 10% get to.
Principles of Effective Drug Addiction Treatment Health 10 The Truth About Drugs Ms. Meade.
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
CHAPTER 2: Terms, Models, and Ethical Issues in Substance Abuse and Addiction Substance Abuse and Addiction Treatment: Practical Application of Counseling.
1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 37 Alcohol, Tobacco and.
KAREN BAILEY, KINGS COLLEGE LONDON NATIONAL ADDICTION CENTRE
Presenter: Tina Chapman
Principles of Harm Reduction
The Burden of Tobacco Use
Concepts of Fitness & Wellness 8e
Syllabus Content Health promotion approaches and strategies
- Scientists are continually developing new drugs
Addressing dual diagnosis within a residential treatment programme serving women with complex needs Anita Harris.
January 2019 ROSC Seminar.
What is it? What causes it? What can we do about it?
Presentation transcript:

A History of the Harm Reduction Movement Northern California - Kaiser Permanente Conference Presenter: Don McVinney, MSSW, M.Phil., ACSW, C-CATODSW, CASAC National Director of Education and Training Harm Reduction Coalition, New York

Historical Methodology and Theoretical Framework History is considered to be a social science (Tuchman, 1994; Tyson, 1995) –According to Tuchman: “Any social phenomenon must be understood in its historical context” In historical research, time is the primary variable: “…history is the record of events, and of patterns of problems, proceeding through time…” (Elton, 1967, 2002; p. 117). Memory, both individual and collective (“social memory” Bentley, 1999, p. 155), is another, although this variable is more often related to biographical and autobiographical, or life, history (Carr, 1986; Cohler, 1994; Smith, 1994).

Historical Methodology and Theoretical Framework Concepts of time in the West, until recently, have been “divided” into past, present, and future time (Koselleck, 1985; Lowith, 1949). More recently, concepts of pre-modern, modern, and now post-modern time have been articulated (Giddens, 1991; Jameson, 1990).

Historical Methodology and Theoretical Framework According to Rosen, “From the postmodern viewpoint, there are no totalizing ‘grand narratives’ that hold true, transcending all cultures across time” (Rosen, 1998, p. 265)

Historical Methodology and Theoretical Framework Social constructionist theory emerged in the field of sociology with the publication of The Social Construction of Reality (Berger & Luckman, 1966; Franklin, 1998). Social constructionism posits that there is no “objective” reality or truth, but multiple realities and truths that are socially ‘engineered,’ ‘created,’ or ‘constructed.’

Historical Methodology and Theoretical Framework As Joan Laird, a social work educator has written, “Postmodernists teach us that history itself is a changing narrative, open to endless recasting, that experiences are not ‘real’ until they are interpreted, given meaning in language; meanings themselves are contextual and intersubjective, co- created in dialogue with others. Knowledge does not develop from ‘proven’ or empirically-tested theory or hypothesis, it does not reflect an objective truth but is rather a product of social discourse; particular ‘knowledges’ are seen as social constructions, stories that have been shaped in contexts of relationships or power. Certain knowledges achieve dominance, become accepted as truth, re-creating, then, the contexts of power relationships in which they were crafted (Laird, 1993, p. 4).

Historical Approaches in the U.S. to Address Alcohol/Drug Use Creating categories of ‘licit’ and ‘illicit’ –Most substances that are now illicit were legal at one time: morphine, cocaine, marijuana/cannabis; LSD; Ecstasy Locating the problem in the person, not the substance (Solution: Demand reduction; moral theory) Locating the problem in the substance, not the person (Solution: Prohibition; Criminal justice model: ‘War on drugs’; Supply reduction) Harm reduction movement: Locates the problem in the relationship between the person and the substance (drug, set, and setting), which may change over time

Harm Reduction and Health Promotion Definition: Harm Reduction is a perspective and a set of practical strategies to reduce the negative consequences of drug use, incorporating a spectrum of strategies from safer use to abstinence.

Harm Reduction Movement: Conceptually Four Phases Implicit and Explicit Implicit harm reduction strategies 1960’s in US: Growing awareness of the health consequences of tobacco and excessive alcohol consumption Framed in public health terms as a threat to the health of the community with social costs Banning these substances was unrealistic, so new measures were devised to reduce harm

Phase One: Implicit Harm Reduction for Alcohol Prevention models (Public Health): “Be Smart, Don’t Start”-type campaigns Policy Models –Minimum drinking age laws –Drunk driving laws –Alcohol server training and interventions –Restricted sales and taxation –Designated driver and van initiatives –Bottle labeling: Alcohol content; warnings to pregnant women

Phase One: Implicit Harm Reduction for Nicotine 1964: Surgeon General’s report linked smoking to cancer and heart disease Simplistic public health message: “Don’t start; if you already smoke, quit.”

Strategies for Addictive Use of Nicotine Prevention strategies: reduce recruitment of new smokers (regulate advertising) Increase cessation (pubic information; taxation) Reduce risks of smoking (“safer cigarettes” such as filters; lower tar and nicotine; “switching” to nicotine enhanced chewing gum) Reduce second-hand smoke (environmental policies)

Phase Two: Implicit Harm Reduction 1970’s Methadone treatment Approved for substitution therapy for dependence to opiates Used in detox: to alleviate withdrawal symptoms Used in MTA models of treatment: Methadone to Abstinence in “short” timeframe (usually 6 months) MMTP: Methadone maintenance: Potentially and practically: Lifelong intervention

Six Domains of Psychosocial Functioning Social (including family relationships) or recreational Physical health Mental health Spirituality Legal or financial Vocational (work or school)

Phase Three: Explicit Harm Reduction: Late 1970’s –1990’s Disease prevention model: To reduce transmission (primary or secondary prevention) of blood-borne pathogens such as HIV or Viral Hepatitis –1970’s: Drug user organizing in Netherlands to reduce spread of viral Hepatitis B (“Junkie Unions”) –80’s HIV/AIDS prevention from activists: Needle exchange –1990: Birth of a “Movement” at the First International Conference on the Reduction of Drug Related Harm, Liverpool, UK

Harm Reduction in the U.S Presentation: “The Mersey Harm- Reduction Model: A Strategy for Dealing with Drug Users,” given by Russell Newcombe and Allan Parry at the International Conference on Drug Policy Reform, Bethesda, Maryland

Principles of Harm Reduction The Merseyside Model HIV is a greater threat than drug use Abstinence therefore should not be the only goal, or necessarily the first goal Reach out to users and engage them Provide innovative services Use a multi-disciplinary approach

Harm Reduction in the U.S. Disease Prevention and Social Justice Late 1980’s: Edith Springer, a trainer from New York, visits UK and the Netherlands and returns to promote harm reduction and create a harm reduction movement through training 1988: First above ground needle exchange: Tacoma, Washington 1988: Needle exchange in New York City-DOH 1993: Harm Reduction Working Group formed; half of whom are people of color who saw harm reduction as a social justice movement

Phase Four: Explicit Harm Reduction 2000’s Broader applications than disease prevention Using behavior change models and motivational enhancements, harm reduction strategies are used in: DV/IPV programs (“safety planning”); dual diagnosis programs (medication adherence); housing programs (“housing first”)

Harm Reduction in the U.S. Disease Prevention and Social Justice 1994: Harm Reduction Coalition incorporated in San Francisco 1995: First Regional Harm Reduction conference held in New York City 1996: Oakland and New York offices of HRC opened 1996: First National Harm Reduction Conference held in Oakland, CA 1998: Bridging the Gap conference held in SF (

San Francisco’s Treatment on Demand Guidelines 1. Providers of services for those who misuse or abuse alcohol or other drugs shall deliver care in a culturally competent, nonjudgmental manner which demonstrates respect for individual dignity, personal strength, and self-determination. 2. Service providers are responsible to the wider community for delivering interventions which will reduce the economic, social, and physical consequences of substance abuse and misuse. 3. Because those engaged in active substance use are often difficult to reach through traditional service venues, in order to reduce risk the service continuum must seek creative opportunities and develop new strategies to engage, motivate, and intervene with potential clients.

San Francisco’s Treatment on Demand Guidelines 4. The goal of substance abuse treatment services is to decrease the short and long term adverse consequences of substance abuse, even for those who continue to use drugs. 5. Comprehensive treatments for those who misuse or abuse drugs and/or alcohol must include strategies that reduce harm for those clients who are unable or unwilling to stop using, and for their loved ones. 6. Relapse or periods of return to use should not be equated with or conceptualized as "failures of treatment."

San Francisco’s Treatment on Demand Guidelines 7. Medical services are an important component of comprehensive substance abuse treatment; patients prescribed medications for the treatment of medical and psychiatric conditions, including addiction, must have full access to substance abuse treatment services. Many methadone consumers, patients with serious medical conditions, and dually or triply diagnosed patients are prohibited from accessing services and support from substance abuse treatment programs. As more medications are shown to be effective in treating addictive, physical, and mental conditions, programs must broaden their treatment philosophies in order to provide quality comprehensive care. Patients should never be denied access to, restricted from participation in, or terminated from treatment in a substance abuse program solely on the basis of their use of a medication prescribed for their treatment. Medications include, but are not limited to, methadone, anti- depressants, and psychotropics. 8. Each program within a system of comprehensive services will be stronger by working collaboratively with other programs in the system.

Elements of Harm Reduction Programs User involvement Any positive change Supportive agency policy Collaborations with other providers

Harm Reduction Movement in the Present 2006: Sixth National Harm Reduction Conference to be held in November in Oakland, CA